RS49583B - Karbapenem antibiotik, kompozicija i postupak za dobijanje - Google Patents

Karbapenem antibiotik, kompozicija i postupak za dobijanje

Info

Publication number
RS49583B
RS49583B YUP-41/98A YU4198A RS49583B RS 49583 B RS49583 B RS 49583B YU 4198 A YU4198 A YU 4198A RS 49583 B RS49583 B RS 49583B
Authority
RS
Serbia
Prior art keywords
preparation
composition
carbapenem antibiotic
hydrate
independent
Prior art date
Application number
YUP-41/98A
Other languages
English (en)
Inventor
Jeffrey ZIMMERMAN
M. John WILLIAMS
A. Paul BERGQUIST
M. Lisa DiMICHELE
C. David DuBOST
J. Michael KAUFMAN
R. Daniel SIDLER
A. William HUNKE
Original Assignee
Merck & Co. Inc.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26309530&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS49583(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9612668.5A external-priority patent/GB9612668D0/en
Application filed by Merck & Co. Inc., filed Critical Merck & Co. Inc.,
Publication of YU4198A publication Critical patent/YU4198A/sh
Publication of RS49583B publication Critical patent/RS49583B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/887—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with a hetero atom or a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Farmaceutska kompozicija naznačena time, što se sastoji od jedinejnja prdstavljenog formulom I: ili njegove farmaceutski prihvatljive soli, stabilizovanog oblika ili hidrata, u kombinaciji sa izvorom ugljen dioksida. Prijava sadrži još 2 nezavisna i 18 zavisnih patentnih zahteva. <patent>
YUP-41/98A 1996-05-28 1997-05-23 Karbapenem antibiotik, kompozicija i postupak za dobijanje RS49583B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1851896P 1996-05-28 1996-05-28
GBGB9612668.5A GB9612668D0 (en) 1996-06-18 1996-06-18 Carbapenem antibiotic composition and method of preparation

Publications (2)

Publication Number Publication Date
YU4198A YU4198A (sh) 1998-12-23
RS49583B true RS49583B (sr) 2007-04-10

Family

ID=26309530

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-41/98A RS49583B (sr) 1996-05-28 1997-05-23 Karbapenem antibiotik, kompozicija i postupak za dobijanje

Country Status (34)

Country Link
EP (1) EP0863901B1 (sr)
JP (2) JPH11509871A (sr)
KR (2) KR100403497B1 (sr)
CN (1) CN1067074C (sr)
AT (1) ATE252584T1 (sr)
AU (1) AU710102B2 (sr)
BG (1) BG63821B1 (sr)
CA (1) CA2227994C (sr)
CO (1) CO4940412A1 (sr)
CY (1) CY2437B1 (sr)
CZ (1) CZ296381B6 (sr)
DE (1) DE69725696T2 (sr)
DK (1) DK0863901T3 (sr)
DZ (1) DZ2242A1 (sr)
EA (1) EA000534B1 (sr)
EE (1) EE04678B1 (sr)
ES (1) ES2208907T3 (sr)
HK (1) HK1016176A1 (sr)
HR (1) HRP970281B1 (sr)
HU (1) HU229426B1 (sr)
ID (1) ID16974A (sr)
IL (1) IL123078A (sr)
IS (1) IS2353B (sr)
MX (1) MX9800808A (sr)
NO (1) NO323815B1 (sr)
NZ (1) NZ329649A (sr)
PL (1) PL188917B1 (sr)
PT (1) PT863901E (sr)
RS (1) RS49583B (sr)
SI (1) SI0863901T1 (sr)
SK (1) SK284359B6 (sr)
TR (1) TR199800146T1 (sr)
TW (1) TW434014B (sr)
WO (1) WO1997045430A1 (sr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998018800A1 (en) * 1996-10-28 1998-05-07 Merck & Co., Inc. Stabilized carbapenem antibiotic compositions and method of making
NZ500955A (en) * 1997-06-16 2001-06-29 Merck & Co Inc Stabilized 1-beta-methyl-carbapenem intermediates and synthetic use
US6180783B1 (en) * 1997-06-16 2001-01-30 Merck & Co., Inc. Stabilized carbapenem intermediates and improved process for carbapenem synthesis
US6504027B1 (en) 1998-03-02 2003-01-07 Merck & Co., Inc. Decarboxylation process for synthesizing carbapenem antibiotics
WO2001032172A1 (en) * 1999-10-29 2001-05-10 Merck & Co., Inc. Process for formulation of carbapenem antibiotic compositions
AR035728A1 (es) 2001-01-16 2004-07-07 Merck & Co Inc Proceso perfeccionado para la sintesis de carbapenem
CN101357918B (zh) * 2007-06-22 2011-05-18 山东轩竹医药科技有限公司 含有异硫脲基巯基吡咯烷的培南衍生物
CN101367815B (zh) * 2007-06-28 2012-07-04 山东轩竹医药科技有限公司 六元环甲酰胺取代的巯基吡咯烷碳青霉烯化合物
EP2229944A1 (en) 2007-12-12 2010-09-22 Dainippon Sumitomo Pharma Co., Ltd. Preparation composition
CN101550138B (zh) * 2008-04-03 2011-05-18 山东轩竹医药科技有限公司 巯基氮杂环烷酰胺醇取代的培南衍生物
EP2505190A1 (en) * 2008-06-11 2012-10-03 Ranbaxy Laboratories Limited Polymorphic forms of ertapenem monosodium salt and process for it's preparation
EP2415758B1 (en) 2009-03-31 2017-03-01 Mitsubishi Materials Electronic Chemicals Co., Ltd. Fluorine-containing n-alkyl sulfonyl imide compound, manufacturing method therefor, and method of manufacturing an ionic compound
CN102803649A (zh) 2009-06-25 2012-11-28 国际壳牌研究有限公司 注水系统和方法
US8889384B2 (en) 2010-10-07 2014-11-18 Shell Oil Company Process for the production of alcohols from biomass
CN103189526B (zh) 2010-11-05 2015-07-08 国际壳牌研究有限公司 处理生物质以产生可用于生物燃料的材料
US8609379B2 (en) 2010-12-20 2013-12-17 Shell Oil Company Process for the production of alcohols from biomass
PL2791344T3 (pl) 2011-12-15 2016-08-31 Shell Int Research Sposób obróbki produktów ubocznych z wytwarzania etanolu
IN2014DN09550A (sr) 2012-05-17 2015-07-17 Shell Int Research
CN103860485A (zh) * 2012-12-18 2014-06-18 深圳市海滨制药有限公司 一种厄他培南钠冻干制剂及其制备方法
CN106232826A (zh) 2014-04-17 2016-12-14 国际壳牌研究有限公司 生产发酵产品的方法
CA2954306C (en) 2014-08-14 2022-08-30 Shell Internationale Research Maatschappij B.V. Process for preparing furfural from biomass

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES525492A0 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
CA2091309A1 (en) * 1992-03-26 1993-09-27 Frederic H. Jung Antibiotic compounds

Also Published As

Publication number Publication date
IS4663A (is) 1998-01-27
YU4198A (sh) 1998-12-23
PL188917B1 (pl) 2005-05-31
HUP9901567A2 (hu) 1999-09-28
ES2208907T3 (es) 2004-06-16
MX9800808A (es) 1998-04-30
IL123078A0 (en) 1998-09-24
CY2437B1 (en) 2004-11-12
NO980380L (no) 1998-03-16
IS2353B (is) 2008-04-15
EP0863901A1 (en) 1998-09-16
HK1016176A1 (en) 1999-10-29
NO323815B1 (no) 2007-07-09
PT863901E (pt) 2004-02-27
EA199800180A1 (ru) 1998-08-27
DE69725696D1 (de) 2003-11-27
CZ25398A3 (cs) 1998-07-15
CZ296381B6 (cs) 2006-03-15
EP0863901B1 (en) 2003-10-22
CA2227994C (en) 2002-06-25
WO1997045430A1 (en) 1997-12-04
DZ2242A1 (fr) 2002-12-18
HUP9901567A3 (en) 2000-03-28
CA2227994A1 (en) 1997-12-04
JPH11509871A (ja) 1999-08-31
EE04678B1 (et) 2006-08-15
CN1198162A (zh) 1998-11-04
NO980380D0 (no) 1998-01-28
PL324746A1 (en) 1998-06-08
TR199800146T1 (xx) 1998-06-22
ATE252584T1 (de) 2003-11-15
HRP970281A2 (en) 1998-06-30
ID16974A (id) 1997-11-27
JP2009084284A (ja) 2009-04-23
DK0863901T3 (da) 2004-02-16
EE9800022A (et) 1998-08-17
IL123078A (en) 2002-03-10
KR19990036052A (sr) 1999-05-25
KR100344479B1 (ko) 2002-10-31
HRP970281B1 (en) 2002-04-30
EA000534B1 (ru) 1999-10-28
AU710102B2 (en) 1999-09-16
DE69725696T2 (de) 2004-07-29
HU229426B1 (en) 2013-12-30
CN1067074C (zh) 2001-06-13
BG63821B1 (bg) 2003-02-28
SI0863901T1 (en) 2004-04-30
CO4940412A1 (es) 2000-07-24
JP5255983B2 (ja) 2013-08-07
SK10998A3 (en) 1998-08-05
BG102273A (bg) 1998-09-30
NZ329649A (en) 1998-11-25
AU3077597A (en) 1998-01-05
TW434014B (en) 2001-05-16
KR100403497B1 (ko) 2003-10-30
SK284359B6 (sk) 2005-02-04

Similar Documents

Publication Publication Date Title
RS49583B (sr) Karbapenem antibiotik, kompozicija i postupak za dobijanje
AU6645998A (en) Oxygen or sulfur containing heteroaromatics as factor xa inhibitors
NZ333385A (en) Solid oral dosage forms containing 35% of valsartan
RS49688B (sr) Novi derivat 3-aril-2- hidroksipropionske kiseline (i)
MY115662A (en) Novel compounds with analgesic effect
AU2420897A (en) Meta-substituted phenylene sulphonamide derivatives
AU2733997A (en) N-(amidinophenyl)-n&#39;-(subst.)-3h-2,4-benzodiazepin-3-one derivatives as factor xa inhibitors
HK1044527A1 (zh) 對位取代的苯乙烯衍生物和其作為整合素劑的用途
AU4064597A (en) Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof
SK1452000A3 (en) Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists
AU5727899A (en) Diaminocyclobutene-3,4-dione derivatives, their preparation and use
IL137794A0 (en) Streptogramin derivatives, preparation method and compositions containing same
ZA974573B (en) Carbapenem antibiotic, composition and method of preparation.
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
GB2333294A (en) Cytokine production inhibitors
MY116202A (en) Carbapenem antibiotic, composition and method of preparation
AU3091795A (en) Inhibition of leukotriene biosynthesis with urea derivatives
ECSP972136A (es) Composicion y metodo de preparacion de un antibiotico de carbapemen